Search for: "Apotex"
Results 441 - 460
of 1,051
Sorted by Relevance
|
Sort by Date
31 Aug 2011, 2:30 am
Highlights this week included: Fortical (Calcitonin) – US: CAFC affirms summary judgment of nonobviousness of Fortical formulation: Unigene v Apotex (Orange Book Blog) (Patent Docs) (IPBiz) US: Google to pay $500 million regarding pharmacy advertising; What is next? [read post]
11 Jan 2009, 11:10 pm
Apotex (the SSRI preemption case about which we previously posted here, among many other places), which suggests the Court may be holding Colacicco pending its decision in Wyeth v. [read post]
12 Sep 2007, 12:18 pm
Apotex, Inc. [read post]
18 Jun 2007, 8:19 pm
Apotex manifest fundamental misunderstandings of chemical practice case law. [read post]
4 Nov 2009, 4:03 am
Stakeholders react to draft report (IP Watch) US: District Court S D New York denies motions to dismiss in gene patent case: Association for Molecular Pathology v USPTO (Inventive Step) (Patent Docs) (Patent Baristas) (Ars Technica) (The IP Factor) (Patently-O) (IP Watch) Products Ceclor (Cefaclor) – Canada: Eli Lilly successful in patent infringement action against Apotex (Pharmacapsules @ Gowlings) Oxytrol (Oxybutynin) – US: Watson and Barr settle patent litigation… [read post]
19 Dec 2008, 1:00 pm
$16.8 million for Alphapharm and Mylan: Takeda v Mylan (Patent Baristas) (Patent Docs) Boniva (Ibandronic acid) – US: Apotex challenges validity of Hoffmann-La Roche’s Boniva patent (Law360) Boniva (Ibandronic acid) – US: Orchid Chemicals & Pharmaceuticals and Orgenus Pharma seek declaratory judgment of invalidity and noninfringement in patent infringement suit brought by Hoffmann-La Roche over Boniva (Law360) Cardizem (Diltiazem) – Antitrust,… [read post]
18 Apr 2007, 4:39 pm
If and when the mandate effectuating the panel's March 22 decision issues in the Apotex case, Apotex's ANDA will not be blocked by Pfizer's pediatric exclusivity. [read post]
4 Nov 2009, 4:03 am
Stakeholders react to draft report (IP Watch) US: District Court S D New York denies motions to dismiss in gene patent case: Association for Molecular Pathology v USPTO (Inventive Step) (Patent Docs) (Patent Baristas) (Ars Technica) (The IP Factor) (Patently-O) (IP Watch) Products Ceclor (Cefaclor) – Canada: Eli Lilly successful in patent infringement action against Apotex (Pharmacapsules @ Gowlings) Oxytrol (Oxybutynin) – US: Watson and Barr settle patent… [read post]
13 May 2015, 4:00 am
Apotex Inc. v. [read post]
4 Nov 2009, 4:03 am
Stakeholders react to draft report (IP Watch) US: District Court S D New York denies motions to dismiss in gene patent case: Association for Molecular Pathology v USPTO (Inventive Step) (Patent Docs) (Patent Baristas) (Ars Technica) (The IP Factor) (Patently-O) (IP Watch) Products Ceclor (Cefaclor) - Canada: Eli Lilly successful in patent infringement action against Apotex (Pharmacapsules @ Gowlings) Oxytrol (Oxybutynin) - US: Watson and Barr settle patent litigation (SmartBrief) Plavix… [read post]
7 Jul 2020, 6:04 am
Apotex Inc., the defendants converted their Paragraph IV certifications for certain patents at issue to Paragraph III certifications. [read post]
20 Dec 2012, 12:20 pm
Apotex Corp. is a United States affiliate of the Canadian Company Apotex Inc. [read post]
31 Oct 2023, 6:31 am
Apotex (Apotex Corp.) [read post]
31 Oct 2023, 6:31 am
Apotex (Apotex Corp.) [read post]
31 Oct 2023, 6:31 am
Apotex (Apotex Corp.) [read post]
14 Mar 2013, 4:00 am
At present, both Patanol and Apotex’s generic are listed on the Ontario formulary (as of January 29, 2013). [read post]
6 Jul 2017, 3:15 am
Cooperstock, 2017 FC 616 https://t.co/ZNHOe0Brjg -> Good case for establishing criteria for collateral contracts Innotech Aviation v Skylink Express 2017 NSSC 176 https://t.co/rcZj2pOks4 -> Link to Supreme Court case abolishing the promise doctrine in Canada AstraZeneca Canada v Apotex Inc. 2017 SCC 36 https://t.co/5CMCa5ys0J -> NDP MP apologizes for plagiarizing parts of an op-ed column https://t.co/LYSf14x0ce -> Feds to widen scope of $1.26B business innovation fund to cover… [read post]
8 Oct 2019, 4:45 am
Three drugmakers – Apotex, Sandoz and GlaxoSmithKline – have recalled generic versions. [read post]
7 Aug 2006, 1:47 pm
Apotex, Inc., (Eastern District of Pennsylvania decided May 25, 2006), if the FDA gives its approval of the drug, no consumer, regardless of the injuries sustained, may bring a failure to warn case against the drug manufacture. [read post]
11 Apr 2014, 11:29 am
Apotex Inc., No. 2013-1128, -1161, -1162, -1163, -1164 (April 11, 2014).IssueThe issue in this case is whether it would have been obvious at the time of invention to select a once monthly oral dosing regimen of ibandronate to treat osteoporosis and to set that dose at 150 mg [based on prior art references teaching a daily dosage amount].Hoffmann-La Roche, Inc. at *9 (text added).Holding[T]he prior art pointed to a monthly treatment of 150 mg of ibandronate. [read post]
